Gene · 7086
Papers3,154
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,154
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Extraordinary therapeutic effect of PSMA radioligand therapy in treatment-refractory progressive metastatic prostate cancer with the transketolase inhibitor benfo-oxythiamine as a radiosensitizer-A case report. | Front Med (Lausanne) | 2024 | 39444815 | PubTator, text mining | PubMed |
| scCTS: identifying the cell type-specific marker genes from population-level single-cell RNA-seq. | Genome Biol | 2024 | 39402623 | PubTator, text mining | PubMed |
| Deciphering Proteomic Expression in Inflammatory Disorders: A Mass Spectrometry Exploration Comparing Infectious, Noninfectious, and Traumatic Brain Injuries in Human Cerebrospinal Fluid. | Neurotrauma Rep | 2024 | 39391051 | PubTator, text mining | PubMed |
| Spatial distribution of teenage pregnancy and its associated factors in Ethiopia: spatial and multilevel analysis of EDHS 2019. | Arch Public Health | 2024 | 39327596 | PubTator, text mining | PubMed |
| Cutaneous Squamous Cell Carcinoma in Transketolase Deficiency. | JAMA Otolaryngol Head Neck Surg | 2024 | 39325476 | PubTator, text mining | PubMed |
| Genetic optimization of the human gut bacterium Phocaeicola vulgatus for enhanced succinate production. | Appl Microbiol Biotechnol | 2024 | 39283347 | PubTator, text mining | PubMed |
| Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma. | Sci Rep | 2024 | 39251709 | PubTator, text mining | PubMed |
| A challenging interplay between basic research, technologies and medical education to provide therapies based on disease mechanisms. | Front Med (Lausanne) | 2024 | 39228799 | PubTator, text mining | PubMed |
| Pharmacological Doses of Thiamine Benefit Patients with the Charcot-Marie-Tooth Neuropathy by Changing Thiamine Diphosphate Levels and Affecting Regulation of Thiamine-Dependent Enzymes. | Biochemistry (Mosc) | 2024 | 39218016 | PubTator, text mining | PubMed |
| Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis/chronic fatigue syndrome by pentose phosphate pathway. | J Cent Nerv Syst Dis | 2024 | 39161795 | PubTator, text mining | PubMed |
| Identification of Oxidative Stress-Related Biomarkers for Pain-Depression Comorbidity Based on Bioinformatics. | Int J Mol Sci | 2024 | 39125922 | PubTator, text mining | PubMed |
| Comprehensive microarray analysis of severe preeclampsia placenta to identify differentially expressed genes, biological pathways, hub genes, and their related non-coding RNAs. | Placenta | 2024 | 39121584 | PubTator, text mining | PubMed |
| How photosynthetic performance impacts agricultural productivity in hybrid cotton offspring. | Heliyon | 2024 | 39114073 | PubTator, text mining | PubMed |
| HMGA1 promotes the progression of esophageal squamous cell carcinoma by elevating TKT-mediated upregulation of pentose phosphate pathway. | Cell Death Dis | 2024 | 39080260 | PubTator, text mining | PubMed |
| Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 study. | Diabetes Metab Res Rev | 2024 | 38961642 | PubTator, text mining | PubMed |
| ECT2 promotes the occurrence and is a prognostic biomarker of head and neck squamous cell carcinoma. | J Cancer | 2024 | 38947403 | PubTator, text mining | PubMed |
| Imidazole Carbamates as a Promising Alternative for Treating Trichomoniasis: In Vitro Effects on the Growth and Gene Expression of Trichomonas vaginalis. | Molecules | 2024 | 38893461 | PubTator, text mining | PubMed |
| Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy. | Biomed Pharmacother | 2024 | 38876050 | PubTator, text mining | PubMed |
| ALK-rearranged mesenchymal neoplasms: a clinicopathological and molecular study of eight additional cases of an emerging group of tyrosine kinase fusion mesenchymal tumours. | J Clin Pathol | 2024 | 38839088 | PubTator, text mining | PubMed |
| Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam). | PLoS One | 2024 | 38809849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7086/papers?page=7